
Cytomegalovirus infection in a splenectomized with β ‐thalassemia major: immunocompetent or immunosuppressed?
Author(s) -
Liatsos George D.,
Pirounaki Maria,
Lazareva Angelina,
Kikezou Georgia,
Dourakis Spyridon P.
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1001
Subject(s) - medicine , immunosuppression , thalassemia , cytomegalovirus , cytomegalovirus infection , context (archaeology) , immunology , disease , cytomegalovirus infections , intensive care medicine , human cytomegalovirus , virus , viral disease , herpesviridae , paleontology , biology
Key Clinical Message We should possibly revise our knowledge about risk assessment of splenectomized individuals with β ‐thalassemia major. Besides their known risk of certain bacterial infection, they might be also in a risk of life‐threatening primary cytomegalovirus ( CMV ) infection and end‐, multi‐organ disease, in the context of their immunosuppression status. Prompt and appropriate treatment initiation can be life saving.